August 18, 2018
Posted in Uncategorized

Phase 3 Vaccine for Clostridium Difficile (C. diff) Aug. 16, 2018 [BioPharmaDive] Pfizer is entering phase 3 clinical trials for a Clostridium difficile (C. diff) infection vaccine; the trial will last more than three years and enroll 16,000 participants. Read full article here Bezlotoxumab for Prevention of Recurrent Clostridium Difficile …

August 3, 2018

We won! Following strong pushback from Peggy Lillis Foundation, The Leapfrog Group, and many other individuals and organizations, the Centers for Medicare and Medicaid Services (CMS) announced yesterday (August 2, 2018) that it will continue the public reporting of Clostridium difficile and other healthcare-associated infections (HAIs).  In May, CMS proposed a rule …